Department of Anesthesiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA Department of Anesthesiology, Stanford University School of Medicine, Stanford, CA, USA.
Pain. 2012 Feb;153(2):366-372. doi: 10.1016/j.pain.2011.10.032. Epub 2011 Dec 1.
The complement system is an important part of innate immunity. Complement activation generates a set of effector molecules with diverse biological functions. C5a is a crucial terminal component of the complement cascade. Several reports suggest that C5a can support nociceptive sensitization and inflammation in various models, including models of incisional pain. However, information concerning the differential effects of C5a on specific modalities of nociception, the role of C5a in supporting neutrophil infiltration, secondary nociceptive mediator generation, and the location of the relevant populations of C5a receptors supporting incisional sensitization are needed. In these studies we utilized C5a receptor-null mice (C5aR(-/-)) and matched controls to study nociceptive changes after hind paw incision. Heat hyperalgesia and mechanical allodynia were measured for 4 days after incision. We also followed hind paw edema, wound area neutrophil infiltration using the myeloperoxidase assay, and interleukin-1β and nerve growth factor levels using both enzyme-linked immunosorbent assay and immunohistochemical techniques. The main findings were: (1) Heat vs mechanical nociceptive sensitization after incision were differentially reduced in C5aR(-/-) mice, with thermal sensitization affected throughout the postincisional period but mechanical sensitization affected only at later time points; (2) Edema developed after incision in wild-type mice but only slightly and transiently in C5aR(-/-) mice, and (3) Deletion of C5aR blocked interleukin-1β and nerve growth factor production near the wound site. These findings demonstrate that the complement system component C5a is a novel biomarker and mediator associated with postsurgical nociceptive processing. C5aR may provide a novel target for the control of pain and inflammation after surgery.
补体系统是先天免疫系统的重要组成部分。补体激活产生了一系列具有多种生物学功能的效应分子。C5a 是补体级联反应的关键末端成分。有几项报告表明,C5a 可以在各种模型中支持伤害感受敏化和炎症,包括切口疼痛模型。然而,关于 C5a 对特定伤害感受模式的差异影响、C5a 在支持中性粒细胞浸润、继发性伤害感受介质生成中的作用以及支持切口敏化的相关 C5a 受体群体的位置等信息尚需进一步研究。在这些研究中,我们利用 C5a 受体缺失小鼠(C5aR(-/-))和匹配的对照来研究后爪切口后的伤害感受变化。在切口后 4 天测量热痛觉过敏和机械性痛觉过敏。我们还通过髓过氧化物酶测定法跟踪后爪水肿、伤口面积中性粒细胞浸润,并用酶联免疫吸附试验和免疫组织化学技术跟踪白细胞介素-1β和神经生长因子水平。主要发现如下:(1)C5aR(-/-) 小鼠中切口后热和机械性伤害感受敏化的程度不同,热敏化在整个术后期间受到影响,而机械性敏化仅在后期受到影响;(2)野生型小鼠在切口后出现水肿,但 C5aR(-/-) 小鼠仅出现轻微和短暂的水肿;(3)C5aR 的缺失阻断了伤口部位附近白细胞介素-1β和神经生长因子的产生。这些发现表明,补体系统成分 C5a 是一种与术后伤害感受处理相关的新型生物标志物和介质。C5aR 可能为手术后疼痛和炎症的控制提供一个新的靶点。